Measurement of gp210 autoantibodies in sera of patients with primary biliary cirrhosis

Journal of Clinical Laboratory Analysis

Volumn 21, Issue 4, 2007, Pages 227-231

  Bauer, Alicja ^a   Habior, Andrzej ^a  

^a MEDICAL CENTER FOR POSTGRADUATE EDUCATION   (Poland)

Author keywords

Anti gp210; Autoantibodies; ELISA; Liver; PBC

Indexed keywords

ALANINE; AMINO ACID; ANTINUCLEAR ANTIBODY; ARGININE; ASPARTIC ACID; AUTOANTIBODY; BENZIDINE DERIVATIVE; GLYCINE; GLYCOPROTEIN; GLYCOPROTEIN GP 210; HORSERADISH PEROXIDASE; IMMUNOGLOBULIN G ANTIBODY; LEUCINE; LYSINE; MITOCHONDRION ANTIBODY; POLYSTYRENE; PROLINE; SERINE; SYNTHETIC PEPTIDE; TRYPTOPHAN; TYROSINE; UNCLASSIFIED DRUG;

ADULT; AGED; AMINO ACID SEQUENCE; ANTIBODY BLOOD LEVEL; ANTIBODY DETECTION; ANTIGEN BINDING; ARTICLE; AUTOIMMUNE DISEASE; CELL NUCLEUS MEMBRANE; CONJUGATION; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; OPTICAL DENSITY; POLAND; PRIMARY BILIARY CIRRHOSIS; RELIABILITY; SENSITIVITY AND SPECIFICITY;

ADULT; AGED; AUTOANTIBODIES; CHOLANGITIS, SCLEROSING; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; LIVER CIRRHOSIS, BILIARY; MALE; MIDDLE AGED; NUCLEAR PORE COMPLEX PROTEINS; REPRODUCIBILITY OF RESULTS;

ARMORACIA RUSTICANA;

EID: 34547412844     PISSN: 08878013     EISSN: 10982825     Source Type: Journal    
DOI: 10.1002/jcla.20170     Document Type: Article

References (21)

1. Miles J, Charles P, Riches P. A review of methods available for the identification of both organ-specific and non-organ-specific autoantibodies. Ann Clin Biochem 1998;35:19-47.
2. Van Norstrand MD, Malinchoc M, Lindor KD, et al. Quantitative measurement of autoantibodies to recombinant mitochondrial antigen in patients with primary biliary cirrhosis. Hepatology 1997;25:6-11.
3. Miyachi K, Hankins RW, Matsushima H, et al. Profile and clinical significance of anti-nuclear envelope antibodies found in patients with primary biliary cirrhosis: a multicenter study. J Autoimmun 2003;20:247-254.
4. Jones DE. Autoantigens in primary biliary cirrhosis. J Clin Pathol 2000;53:813-821.
5. Bogdanos D, Pares A, Rodes J, Vergani D. Primary biliary cirrhosis specific antinuclear antibodies in patients from Spain. Am J Gastroenterol 2004;99:763-764.
6. Lozano F, Pares A, Borche L. Autoantibodies against nuclear envelope-associated proteins in primary biliary cirrhosis. Hepatology 1988;8:930-938.
7. Courvalin JC, Lassoued K, Bartnik E, Blobel G, Wozniak RW. The 210-kD nuclear envelope polypeptide recognized by human autoantibodies in primary biliary cirrhosis is the major glycoprotein of the nuclear pore. J Clin Invest 1990;86:279.
8. Nickowitz RE, Worman HJ. Autoantibodies from patients with primary biliary cirrhosis recognize a restricted region within the cytoplasmic tail of nuclear pore membrane glycoprotein gp210. J Exp Med 1993;178:2237-2242.
9. Worman HJ, Courvalin JC. Antinuclear antibodies specific for primary biliary cirrhosis. Autoimmun Rev 2003;2:211D.
10. Bogdanos D. Positive markers in AMA-negative PBC. Am J Gastroenterol 2003;98:241-243.
11. Wesierska-Gadek J, Hohenauer H, Hitchman E, Penner E. Autoantibodies from patients with primary biliary cirrhosis preferentially react with the amino-terminal domain of nuclear pore complex glycoprotein gp210. J Exp Med 1995;182: 1159-1162.
12. Bandin O, Courvalin JC, Poupon R, Dubel L, Homberg JC, Johanet C. Specificity and sensitivity of gp210 autoantibodies detected using an enzyme-linked immunosorbent assay a synthetic polypeptide in diagnosis of primary biliary cirrhosis. Hepatology 1996;23:1020-1024.
13. Nakamura M, Shimizu Y, Yoshida Y, et al. Antibody titer to gp210-C terminal peptide as a clinical parameter for monitoring primary biliary cirrhosis. J Hepatol 2005;42:386-392.
14. Courvalin JC, Lassoused K, Worman HJ, Blobel G. Identification and characterization of antibodies against the nuclear envelope lamin B receptor from patients with primary biliary cirrhosis. J Exp Med 1990;172:961-967.
15. Muratori P, Muratori L, Ferrari R, et al. Characterization and clinical impact of antinuclear antibodies in primary biliary cirrhosis. Am J Gastroenterol 2003;98:431-437.
16. Nickowitz RE, Wozniak RW, Schaffner F, Worman H. Autoantibodies against integral membrane proteins of the nuclear envelope in patients with primary biliary cirrhosis. Gastroenterology 1994;106:193-199.
17. Lassoued K, Brenard R, Degos F. Antinuclear antibodies directed to a 200kD polypeptide of the nuclear envelope in primary biliary cirrhosis: a clinical and immunological study of a series of 150 patients with primary biliary cirrhosis. Gastroenterology 1990;99:181-186.
18. Szostecki C, Guldner HH, Will H. Autoantibodies against "nuclear dots" in primary biliary cirrhosis. Semin Liver Dis 1997;17:71-78.
19. Christensen E, Crowe J, Doniach D. Clinical pattern and course of disease in primary biliary cirrhosis based on an analysis of 236 patients. Gastroenterology 1980;78:236-246.
20. Shimoda S, Nakamura M, Ishibashi H. Molecular mimicry of mitochondrial and molecular autoantigens in primary biliary cirrhosis. Gastroenterology 2003;124:1915-1925.
21. Itoh S, Ichida T. Autoantibodies against a 210 kDa glycoprotein of the nuclear pore complex as a prognostic marker in patients with primary biliary cirrhosis. J Gastroenterol Hepatol 1998;13: 257-265.